Trials / Completed
CompletedNCT02362711
Efficacy and Safety, Long-Term Study of NPC-16 to Treat Dysmenorrhea
Phase3, Placebo Controlled, Randomized, Double-blinded, Long-Term, NSAID-Add-on, Clinical Trial of NPC-16 for Treatment of Dysmenorrhea
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 248 (actual)
- Sponsor
- Nobelpharma · Industry
- Sex
- Female
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this long-term study is to determine whether NPC-16 is effective in the treatment of dysmenorrhea.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | NPC-16 Standard Dosing Regimen Group | |
| DRUG | NPC-16 Continuous Dosing Regimen Group | |
| DRUG | Placebo Group |
Timeline
- Start date
- 2015-02-01
- Primary completion
- 2017-01-01
- Completion
- 2017-01-28
- First posted
- 2015-02-13
- Last updated
- 2019-04-16
Source: ClinicalTrials.gov record NCT02362711. Inclusion in this directory is not an endorsement.